TRENDING LISTS: Dividend Aristocrats, Dow 30, Largest Market Cap Stocks & Warren Buffett's Portfolio

CELG $68.20 -1.54 (-2.21%)

Fri, Dec 14, 2018

Celgene Corp is a Health Care stock that trades on the NASDAQ with a market cap of $63.95 Billion

Celgene is a biopharmaceutical firm that discovers, develops, and markets therapeutics for the treatment of cancer and immunological diseases. Celgene markets Thalomid and Pomalyst to treat multiple myeloma and Revlimid, a less toxic thalidomide derivative, to treat myelodysplastic syndromes, multiple myeloma, and mantle cell lymphoma. Acquisitions have brought MDS drug Vidaza, T-cell lymphoma drug Istodax, and cancer drug Abraxane. The firm's first immunology drug, Otezla, was approved in the U.S. in 2014. Recent acquisitions of Juno and Impact bring additional drugs for Celgene's blood cancer pipeline.

If you haven't signed up for Ebates yet, you are definitely leaving money on the table.

Get up to 12% CASH BACK from shopping @ $AMZN, $WMT and $EBAY & $10 Sign Up Bonus (through this link)!

Ebates Coupons and Cash Back

Add (CELG) to Portfolio

Celgene Corp Stock Charts

The 5 year and 1 year stock charts are below.

50 Day Moving Average

The 50 Day Moving Average is at $74.49 which is 8.44% above the stock price of $68.20.

200 Day Moving Average

The 200 Day Moving Average is at 83.31 which is 18.14% abovethe stock price of $68.20.

CELG Stock Price

Below are a few key dates for the stock price.

Year To Date


The most recent stock price is $68.20.

The Year To Date (YTD) return is -35.76%.

52 Week Low


The 52 Week Low stock price is $66.65 set on Fri, Nov 23, 2018 which is 23 days ago.

The current price per share is 2.33% above the 52 week low.

52 Week High

Dec 2017

The 52 Week High stock price is $109.41 set on Fri, Dec 15, 2017 which is 366 days ago.

The current price per share is -37.67% below the 52 week high.

All Time High

Oct 2017

The All Time High stock price is $146.52 set on Wed, Oct 4, 2017 which is 438 days ago.

The current price per share is -53.45% below the all time high.


Below is the EPS, P/E Ratio and Earnings Date.

The Earnings Per Share (EPS) is $1.54.

The Price To Earnings (P/E) Ratio is 17.70.

Earnings Dates

Stocks can make big percentage moves on the earnings announcement.

Companies announce earnings either before the market open or after the close.


The Earnings Release Date for Celgene Corp was Thu, Jul 26, 2018.

Since this earnings release 143 days ago, the stock price is down by -22.21%.


The most recent Earnings Release Date was on Thu, Oct 25, 2018, which was 52 days ago.

Since this earnings date, the stock price is down by -8.71%.

Celgene Corp Dividend

Below is important Dividend information.

CELG currently does not pay a dividend.

You may like this list of best dividend stocks of 2018.

Industry Stocks

Below are some other Biotech & Pharma industry stocks like Celgene Corp.